LC Application Note.

Similar documents
GC & LC Application Note

A Definitive Lipidomics Workflow for Human Plasma Utilizing Off-line Enrichment and Class Specific Separation of Phospholipids

Extraction of a Comprehensive Steroid Panel from Human Serum Using ISOLUTE. SLE+ Prior to LC/MS-MS Analysis

Analytes. Sample Preparation Procedure. Introduction. Format: Sample Pre-treatment. Sample Loading. Analyte Extraction and Derivatization.

Automated Purification and Analytical Reinjection of a Small Molecule Drug, Probenecid, on a Gilson LC/MS Dual Function System

Cannabinoid Profiling and Quantitation in Hemp Extracts using the Agilent 1290 Infinity II/6230B LC/TOF system

Measuring Lipid Composition LC-MS/MS

Shuguang Li, Jason Anspach, Sky Countryman, and Erica Pike Phenomenex, Inc., 411 Madrid Ave., Torrance, CA USA PO _W

LC-Based Lipidomics Analysis on QTRAP Instruments

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Simultaneous Analysis of Active Pharmaceutical Ingredients and Their Counter-Ions Using a Mixed-Mode Column

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

Qualitative and quantitative determination of cannabinoid profiles and potency in CBD hemp oil using LC/UV and Mass Selective Detection

Using Software Tools to Improve the Detection of Impurities by LC/MS. Application Note. Christine Miller Agilent Technologies.

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system

Vitamin D3 and related compounds by ESI and APCI

SWATH Acquisition Enables the Ultra-Fast and Accurate Determination of Novel Synthetic Opioids

Mass-Based Purification of Natural Product Impurities Using an Agilent 1260 Infinity II Preparative LC/MSD System

Analysis of Rosuvastatin in Dried Blood Spot and Plasma Using ACQUITY UPLC with 2D Technology

Relative Quantitation of Human Polymorphonuclear Leukocyte Cell Membrane GPEtn Lipids

Integration of steroids analysis in serum using LC-MS/MS with full-automated sample preparation

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

Extraction of Multiple Mycotoxins From Grain Using ISOLUTE Myco prior to LC-MS/MS Analysis

Dienes Derivatization MaxSpec Kit

Determination of Amantadine Residues in Chicken by LCMS-8040

Identification & Confirmation of Structurally Related Degradation Products of Simvastatin

AbsoluteIDQ p180 Kit. Targeted Metabolite Identifi cation and Quantifi cation

Separation and Quantitation of Oxysterol Compounds Using LC-MS/MS. Liquid Chromatography Mass Spectrometry SSI-LCMS-082

Ultra High Performance Liquid Chromatograph. Nexera X2 C196-E079

Sample Preparation Techniques for Biological Matrices: Finding the right balance to achieve optimal results

Clinical Mass Spectrometry Case Studies: How we can Read Between the Lines

LC-MS/MS Method for the Determination of Tenofovir from Plasma

Identification of Steroids in Water by Ion Trap LC/MS/MS Application

Designer Cannabinoids

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Profiling of Endogenous Metabolites Using Time-of-Flight LC/MS with Ion Pair Reverse Phase Chromatography

The Raptor HILIC-Si Column

Removal of Triton X-100 from Plasma Samples Using Mixed-Mode Solid Phase Extraction (SPE)

Metabolomic fingerprinting of serum samples by direct infusion mass spectrometry

Application Note. Author. Abstract. Introduction. Food Safety

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

SCIEX Vitamin D 200M Assay for the Topaz System

Application Note. Abstract. Authors. Pharmaceutical

Probing for Packaging Migrants in a Pharmaceutical Impurities Assay Using UHPLC with UV and Mass Detection INTRODUCTION

AbsoluteIDQ p150 Kit. Targeted Metabolite Identifi cation and Quantifi cation. Bringing our targeted metabolomics expertise to your lab.

OMCL Network of the Council of Europe QUALITY MANAGEMENT DOCUMENT

Authors. Abstract. Introduction. Environmental

Step 3: muscle, nasal sprays and drops or used as topical

Matrix Factor Determination with the Waters Regulated Bioanalysis System Solution

SeQuant ZIC -HILIC For all who expect more...

Metabolite identification in metabolomics: Metlin Database and interpretation of MSMS spectra

LC Application Note. Dangerous driver?

Key Advantages of Comprehensive Cannabis Analysis

SeQuant ZIC -HILIC For all who expect more...

Ultra Performance Liquid Chromatography Coupled to Orthogonal Quadrupole TOF MS(MS) for Metabolite Identification

[ APPLICATION NOTE ] Profiling Mono and Disaccharides in Milk and Infant Formula Using the ACQUITY Arc System and ACQUITY QDa Detector

Designer Fentanyls Drugs that kill and how to detect them. Cyclopropylfentanyl

Overview. Introduction. Experimental. Cliquid Software for Routine LC/MS/MS Analysis

MASS SPECTROMETRY IN METABOLOMICS

Method Development for the Analysis of Endogenous Steroids Using Convergence Chromatography with Mass Spectrometric Detection

Agilent 6410 Triple Quadrupole LC/MS. Sensitivity, Reliability, Value

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

Small Molecule Science: Experimental designs for achieving ultra trace analysis

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

Development and Validation of an UPLC-MS/MS Method for Quantification of Mycotoxins in Tobacco and Smokeless Tobacco Products

Determination of Selected Illegal Drugs and its Important Metabolites in Waste Water by Large Volume Direct Injection HPLC-MS/MS

Sample Concentration and Analysis of Human Hormones in Drinking Water

Rapid, Simple Impurity Characterization with the Xevo TQ Mass Spectrometer

Metabolite identification in metabolomics: Database and interpretation of MSMS spectra

The Investigation of Factors Contributing to Immunosuppressant Drugs Response Variability in LC-MS/MS Analysis

Join the mass movement towards mass spectrometry

All stocks and calibration levels were prepared in water: methanol (50:50) v/v to cover range of all steroid concentrations (refer Table 1).

Agilent s LC/MS Portfolio and Applications Examples

Small Scale Preparative Isolation of Corticosteroid Degradation Products Using Mass-Based Fraction Collection Application

Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µelution SPE Combined with UPLC/MS/MS for Forensic Toxicology

GC/MS Application Note

Single Quadrupole Compact Mass Spectrometer for Liquid Sample

you-try-it-02.xlsx Step-by-Step Guide ver. 8/26/2009

Reduced Ion Suppression and Improved LC/MS Sensitivity with Agilent Bond Elut Plexa

Liquid Chromatograph Mass Spectrometer LCMS-8040 C146-E188E

Fast and easy separation of 23 drugs of abuse. including high, stable resolution of isobaric opioids from human urine by UHPLC-MS/MS

Modernizing the Forensic Lab with LC-MS/MS Technology

Run 1 Run 2 TDP PLP TDP PLP. 3.0e5 2.8e5 2.2e5. 2.6e5 2.4e5. 2.2e5 2.0e5. Intensity, cps. 1.8e5 1.6e5 1.4e5 1.2e5 1.0e5 4.0e4. 2.0e e5 1.

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

LC/MS Method for Comprehensive Analysis of Plasma Lipids

Phospholipid characterization by a TQ-MS data based identification scheme

Applying a Novel Glycan Tagging Reagent, RapiFluor-MS, and an Integrated UPLC-FLR/QTof MS System for Low Abundant N-Glycan Analysis

New Solvent Grade Targeted for Trace Analysis by UHPLC-MS

Rapid Lipid Profiling of Serum by Reverse Phase UPLC-Tandem Quadrupole MS

Quantification of lovastatin in human plasma by LC/ESI/MS/MS using the Agilent 6410 Triple Quadrupole LC/MS system

AppNote 1/2015. Automated Sample Preparation for Metabolomics Studies Using the Gerstel MPS Dual Head WorkStation

Quantitative Analysis of Carbohydrates and Artificial Sweeteners in Food Samples Using GFC- MS with APCI Interface and Post-column Reagent Addition

MS/MS as an LC Detector for the Screening of Drugs and Their Metabolites in Race Horse Urine

Performance of an ultra low elution volume 96-well plate

Transcription:

LC Application Note Automation Arrives: Fully integrated automated Bligh and Dyer extraction and dual-column analysis for metabolomics analyses of tissues and cells www.palsystem.com

Automation Arrives Fully integrated automated Bligh and Dyer extraction and dual-column analysis for metabolomics analyses of tissues and cells Emmanuel Varesio, Sandra Jahn, Sandrine Cudré, Gérard Hopfgartner, Life Sciences Mass Spectrometry, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, Switzerland; Renzo Picenoni, Guenter Boehm, Director Applications and Customer Communications, CTC Analytics AG, Zwingen, Switzerland Metabolomic studies provide us with key insights into biological systems and can help improve our understanding of the basis of a disease, elucidate the mechanism of action of a drug, and inform the development of relevant biomarkers. In practice, for metabolites to be studied, they need to be effectively extracted from a sample, a process that can be challenging due to their broad physic-chemical diversity and the potentially large spectrum of concentrations of different metabolites in a single sample. Liquid-liquid extraction is often used to extract metabolites. However the solvents employed as well as the experimental practice must be carefully considered in order to mitigate any risk affecting the quality of the resulting extract. Bligh and Dyer extraction, or one of its variants, such as Folch extraction, has been used for many years and is generally considered an efficient method for the extraction of lipids and polar endogenous metabolites from tissues and cells. 1 However, it is still performed manually, and is a laborious task that is becoming increasingly out of place as laboratories move to automated analysis and handle large sets of samples. to a traditional manual method. Advancing processes Laboratories are constantly challenged to push the limits of analysis. New and improved measurement technology drives detection limits and time to result down. As a consequence, bottlenecks and variability stemming from sample prep have come under the spotlight. Robotic approaches to sample prep are now routine but smart sample prep where robotics interfaces directly to an analyzer, and software integration is also achieved, are much less common. In many laboratory settings automation has proven effective in increasing efficiency and improving repeatability. Streamlining workflow in this way not only increases consistency but allows scientists to devote more time to operations that require their unique skills and experiences. Full integration Sample preparation workflows for metabolomic studies of tissues and cells often require a liquid-liquid extraction (LLE), which takes advantage of differing distribution coefficients to enrich metabolites and to separate them from undesired compounds. Now, an automated Bligh and Dyer extraction on a robotic system has been fully integrated with a dual-column ultra high-pressure liquid chromatography tandem mass spectrometer (UHPLC-MS/MS) platform for the metabolomics analysis of tissues and/or cells (Figure 1). In this article the authors describe recent work that details a fully automated Bligh and Dyer extraction and dual-column UHPLC-MS/MS separation for metabolomic analyses of tissues and cells, and compares the new procedure Figure 1: The PAL RTC robot (CTC Analytics) equipped with several modules as shown. 2 IngeniousNews 04/2015

Instrumentation and software set-up For the LC-separation of the Bligh and Dyer fractions, two quaternary low-pressure Nexera LC30AD UHPLC pumps (Shimadzu) were used. A PAL RTC robot (CTC Analytics) performed the sample prep (as outlined in figure 2), and injected the resulting aqueous fractions onto a 100 x 2.1 mm XBridge BEH C18 XP column (Waters) running alternately with an acidic or a basic mobile phase. The organic (CHCl 3 ) fractions were evaporated to dryness, reconstituted and injected onto a 150 x 2.1 mm XBridge BEH C8 XP column. Both columns were maintained at 40 C. The dual-column UHPLC platform was hyphenated to a TripleTOF 5600 MS (AB Sciex). Mass spectrometry and tandem mass spectrometry data were acquired in positive electrospray ionization (ESI) mode using a Turbo V ion source equipped with an APCI probe. To complement the hardware configuration and allow for true integration the PAL RTC robot was controlled by PAL Sample Control v 2.1 software (CTC Analytics). This interface was linked with the LabSolutions v 5.6 SP2 software (Shimadzu) and used to control the UHPLC system. Sample preparation Figure 2 shows the sample preparation workflow for automated Bligh and Dyer extraction. The method proved to be far more streamlined than conventional sample preparation. Importantly, scientists only had to perform a few manual steps before loading samples onto the PAL RTC robot: initially 1 ml of cold MeOH was added to the raw samples, which were then spun ahead of flash freezing and cryogenic grinding. After the addition of a solution of H 2 O:MeOH:CHCl 3 the sample was then transferred to the PAL RTC robot where it underwent the automated Bligh and Dyer extraction. The RTC platform performed all the necessary extraction steps, splitting the fractions and adding the correct volumes and concentrations of the appropriate reagents and chromatographic standards as needed. The method proved significantly less labor intensive and reduced the overall sample preparation time. Analysis of the upper H 2 O-MeOH fractions was then conducted on UHPLC system 1 with on-line dilution and standard addition by the RTC robot and alternating the ph of the mobile phases. It was found that for polar compounds the peak width increased for injections more than 5 µl. However area ratio remained adequate with up to 10% MeOH in the sample solvent, even with an injection volume of 45 µl. For lipophilic compounds peak width remained at 0.1 min with large injections of 45 µl, but higher organic content in the sample solvent was required. Figure 2: Automated sample preparation workflow for Bligh and Dyer extraction IngeniousNews 04/2015 3

0.25 x 1 2 3 4 5 6 7 anandamide testosterone diclofenac Δ9-tetrahydrocannabinol 17-HO-progesterone cocaine aldosterone cortisol caffeine biotin aspartame melanostatine 5.0e3 0.0e0 3-methoxytyramine 4-pyridoxic acid 1.0e4 theobromine 1.5e4 acetaminophen 2.0e4 nicotine Intensity adenine 3.0e4 2.5e4 metoprolol 3.5e4 8 9 10 11 12 13 min. Figure 3: XIC traces of selected metabolites analyzed on the C18 column with acidic ph. An on-line dilution was necessary to lower the organic content in the sample solvent as the H2O-MeOH Bligh and Dyer fraction contains 50% MeOH. Different dilution factors, with their adapted injection volumes kept the same amount injected on-column, were tested with the PAL RTC robot. volume were detrimental to their peak shape. Conversely, for lipophilic compounds, losses were observed due to poor solubility in mostly aqueous solvent, such as those including only 5 or 10% methanol. However for other compounds, consistent results were observed across the dilution factors. The upper (aqueous) fraction was analyzed with two different mobile phases ( and ) to improve the retention of certain polar compounds, such as adenine and nicotine. When the mobile phases were alternated, the column reconditioning time for the basic ph was critical to ensure the system remained stable. Therefore injection scheme B, as shown in Figure 4 was preferred as each injection was alternated. The lower organic fraction was analyzed on UHPLC system 2. With the automated system, evaporation of 400 µl in 1.2 ml vase vials was achieved in less than seven minutes for CHCl3 and less than 14 minutes for MeOH. After evaporation reconstituted volumes of 100, 150 and 200 µl of MeOH were tested for the organic fraction by injecting 5 µl on the column. It was found that 150 µl were sufficiently concentrated so this sample was chosen for further testing. For highly polar compounds, high organic content or a large injection Only few compounds with amphiphilic properties, such as metoprolol, were 4 IngeniousNews 04/2015 retrieved in both fractions. These results are in agreement with comparative analyses of manually extracted samples. In order to assess the repeatability of the automated Bligh and Dyer extraction process with the RTC platform manual procedures were performed, which also allowed for the comparison of any variation between the two methods. It was found that lower variation and therefore better repeatability was achieved with the automated method throughout all experiments conducted, as shown in Figure 5. By acquiring LC-MS/MS data in SWATH mode, the results could be directly subjected to a library search without the need of performing further targeted experiments, allowing for the fast identification and quantification of certain unknowns. This significantly reduced experimental time and resulted in faster processing of results.

Study A ph B C 0 1 2 3 4 5 6 7 8 9 10 11 12 13 Retention Time [min] Adenine Nicotine Biotin Cocaine Diclofenac 17-HOprogest.. Anandamide THC Figure 4: Retention times of selected compounds (SST 0.2 μg/ml) for three injection schemes: A) Only mobile phase, B) Mobile phase ph alternating every injection, C) Mobile phase ph alternating every second injection. Compound Name Formula MW (g/mol) LogP LogD pka(acid) GALAS pka(base) GALAS (ph=3.0) (ph=8.3) pka Reliability pka Reliability Acetaminophen C 8 H 9 NO 2 151.2 0.40 0.39 0.39 10.2 14.6 0.4 0.5 1.7 0.5 Adenine C 5 H 5 N 5 135.1 0.43-1.10 0.42 9.9 0.4 3.9 0.4 Aldosterone C 21 H 28 O 5 360.4 1.07 1.07 1.07 13.7 15.6 1 0.8 Aspartame C 14 H 18 N 2 O 5 294.3 0.93-1.73-2.41 2.4 11.1 0.4 1.1 7.8 0.4 Biotin C 8 H 10 N 4 O 2 194.2 0.28 0.28 0.28 Caffeine C 8 H 10 N 4 O 2 194.2 0.28 0.28 0.28 Cocaine C 17 H 21 NO 4 303.4 2.78-0.32 2.03 8.6 0.4 Cortisol C 21 H 30 O 5 362.5 1.66 1.66 1.66 13.2 14.5 1 0.9 Diclofenac C 14 H 11 Cl 2 NO 2 296.2 4.48 4.45 0.88 4.4 0.4 17-Hydroxyprogesterone C 21 H 30 O 3 330.5 3.16 3.16 3.16 13.9 0.9 Melanostatin C 13 H 24 N 4 O 3 284.4-0.81-3.91-1.06 10.7 12.4 14.6 1.1 1 0.8 8.2-1.8 0.4 0.5 3-Methoxytyramine C 9 H 13 NO 2 167.2 0.41-2.69-1.03 10.6 0.4 9.4 0.4 Metoprolol C 15 H 25 NO 3 267.4 1.85-1.25 0.59 13.9 0.4 9.5 0.4 Nicotine C 10 H 14 N 2 162.2 0.82-2.92 0.37 8.3 3.2 0.4 0.4 4-Pyridoxic acid C 8 H 9 NO 4 183.2 0.91-1.57-2.24 1.7 10.8 15.3 0.9 1 0.9 4.1 0.5 Testosterone C 19 H 28 O 2 288.4 3.16 3.16 3.16 16 0.8 Theobromine C 7 H 8 N 4 O 2 180.2-0.34-0.34-0.35 9.9 0.4 Table 1: Calculated logp, logd and pka for the SST compounds. Calculated with ACD/Labs Percepta software Release 2012 IngeniousNews 04/2015 5

a) Average Area [-] 3.00E+05 2.50E+05 2.00E+05 1.50E+05 1.00E+05 AQ ph3 automated AQ ph3 manual CV automated CV manual 25.0 20.0 15.0 10.0 CV [%] Figure 5: Column diagrams showing the peak areas of selected variables (by m/z and retention time, RT) as well as variation obtained after analysis of the aqueous (AQ) and organic (ORG) B&D fractions from the automated or the manual extraction procedure (n=5): a) AQ fractions at ph 3 - C18 column, b) AQ fractions at ph 8 - C18 column, c) ORG fractions (ph 4) - C8 column. 5.00E+04 5.0 b) c) 0.00E+00 AQ fraction Average Area [-] 8.00E+05 7.00E+05 6.00E+05 5.00E+05 4.00E+05 3.00E+05 2.00E+05 1.00E+05 0.00E+00 AQ fraction 3.00E+06 2.50E+06 226.2/7.6 228.2/8.2 256.2/8.7 267.2/10.3 283.2/5.1 302.3/9.9 309.2/6.7 317.1/11.1 322.2/6.4 344.2/5.3 354.3/9.7 363.2/7.1 Variable [m/z/rt] AQ ph8 automated AQ ph8 manual CV automated CV manual 122.1/7.1 195.1/4.9 218.2/8.1 226.2/6.2 228.2/8.4 234.2/6.9 239.2/5.1 246.2/9.3 252.1/4.9 256.2/8.7 322.2/5.4 344.2/5.5 354.3/9.8 381.2/6.0 388.3/5.6 432.3/5.8 453.3/6.1 466.2/6.5 476.3/5.8 724.3/7.7 810.4/7.9 Variable [m/z/rt] ORG automated ORG manual CV automated CV manual 381.2/5.7 388.3/5.5 432.3/5.6 453.3/6.0 476.3/5.7 651.6/13.5 761.4/5.7 0.0 45.0 40.0 35.0 30.0 25.0 20.0 15.0 10.0 5.0 0.0 30.0 25.0 CV [%] In conclusion As laboratories are striving to uncover more «unknowns» and increase our understanding of biological processes there is a drive for procedures to become more efficient and repeatable. This is also true for extraction procedures which when performed manually can be time intensive and cumbersome, taking the valuable time of scientists. The automated Bligh and Dyer extraction described here was found to not only be more time efficient, but also to improve repeatability and quality of extraction and separation when compared to the standard manual approach. References [1] S.K. Jensen, Lipid Technology 12/2008, 20(12):280-281 - DOI: 10.1002/lite.200800074 [2] J. Folch, J. Biol. Chem. 1957, 226: 497 [3] E.G.Bligh and W.J. Dyer, Can. J. Biochem. Physiol. 1959, 37: 911-917 Average Area [-] 2.00E+06 1.50E+06 1.00E+06 20.0 15.0 10.0 CV [%] 5.00E+05 5.0 0.00E+00 0.0 ORG fraction 502.3/11.7 600.5/18.9 606.5/20.1 608.5/20.7 609.3/15.4 623.3/16.4 636.6/21.5 704.5/18.6 710.6/19.7 732.6/19.0 734.6/19.5 738.6/20.4 754.6/18.3 756.6/18.6 758.6/18.9 760.6/19.4 762.5/17.9 762.6/20.2 764.5/18.4 924.6/17.2 926.6/17.4 928.6/17.9 934.6/19.2 Variable [m/z/rt] 6 IngeniousNews 04/2015

IngeniousNews 04/2015 7

Legal Statements CTC Analytics AG reserves the right to make improvements and/or changes to the product(s) described in this document at any time without prior notice. CTC Analytics AG makes no warranty of any kind pertaining to this product, including but not limited to implied warranties of merchantability and suitability for a particular purpose. Under no circumstances shall CTC Analytics AG be held liable for any coincidental damage or damages arising as a consequence of or from the use of this document. 2015 CTC Analytics AG. All rights reserved. Neither this publication nor any part hereof may be copied, photocopied, reproduced, translated, distributed or reduced to electronic medium or machine readable form without the prior written permission from CTC Analytics AG, except as permitted under copyright laws. CTC Analytics AG acknowledges all trade names and trademarks used as the property of their respective owners. PAL is a registered trademark of CTC Analytics AG Switzerland Imprint Date of print: 08.2015 CTC Analytics AG Industriestrasse 20 CH-4222 Zwingen Switzerland T +41 61 765 81 00 F +41 61 765 81 99 Contact: info@ctc.ch 8 IngeniousNews 04/2015